Skip to main content
. Author manuscript; available in PMC: 2015 Aug 18.
Published in final edited form as: Steroids. 2013 Nov 20;81:17–25. doi: 10.1016/j.steroids.2013.11.009

Fig. 2.

Fig. 2

Mean (±SEM) lordosis quotients (LQs) of mice administered vehicle (control), mPRα AS-ODNs, mPRβ AS-ODNs, or both mPRα/β AS-ODNs. Panel A: E2 + P4-primed C57/BL6 (“C57”) mice that were administered AS-ODNs intracerebroventicularly (ICV). Panel B: E2 + P4-primed C57/BL6 mice that were administered AS-ODNs to the ventral tegmental area (VTA). Panel C: E2 + P4-primed C57/BL6x129 (“wildtype”) mice that were administered AS-ODNs to the VTA. Panel D: E2 + P4-primed progestin receptor knockout (PRKO) mice that were administered AS-ODNs to the VTA. *indicates significant difference from vehicle control group p < 0.05.